Literature DB >> 33008535

Schizophrenia spectrum and other psychotic disorders.

Richard Lewine1, Mara Hart2.   

Abstract

Since its earliest conceptualization, schizophrenia has been considered a disorder of "young men." Contemporary research suggests that there are sex differences in schizophrenia that are both transdiagnostic and representative of general sex/gender differences across the psychopathology spectrum. This chapter selectively summarizes representative sex/gender differences in clinical expression, epidemiology, risk factors, treatment, as well as course and outcome in schizophrenia. The consistent sex differences found, such as onset age, generic brain anomalies, and hormonal involvement, are not specific to schizophrenia or necessarily to psychopathology. It is suggested that in working with those diagnosed as meeting the current criteria for schizophrenia, clinicians adopt a transdiagnostic framework informed by sex and gender role processes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dimensional classification; Gender; Psychoses; Schizophrenia; Sex

Mesh:

Year:  2020        PMID: 33008535     DOI: 10.1016/B978-0-444-64123-6.00022-9

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  3 in total

1.  Supplementation of PQQ from pregnancy prevents MK-801-induced schizophrenia-like behaviors in mice.

Authors:  Ying Peng; Dong Xu; Yuedi Ding; Xingqin Zhou
Journal:  Psychopharmacology (Berl)       Date:  2022-03-16       Impact factor: 4.530

2.  Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders.

Authors:  Valentina Pugliese; Renato de Filippis; Matteo Aloi; Paola Rotella; Elvira Anna Carbone; Raffaele Gaetano; Pasquale De Fazio
Journal:  Ann Gen Psychiatry       Date:  2022-07-03       Impact factor: 3.301

3.  Proteomic profile of serum from patients with schizophrenia spectrum disorders.

Authors:  Elena Dmitrieva; Liudmila Smirnova; Alexander Seregin; Victor Zgoda; Arkadij Semke; Svetlana Ivanova
Journal:  PeerJ       Date:  2022-08-30       Impact factor: 3.061

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.